The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 56.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 130,486 shares of the medical device company’s stock after acquiring an additional 46,999 shares during the quarter. Quantinno Capital Management LP owned 0.07% of Cooper Companies worth $11,996,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Mufg Securities Americas Inc. acquired a new position in shares of Cooper Companies during the 4th quarter valued at $270,000. Nissay Asset Management Corp Japan ADV increased its position in shares of Cooper Companies by 0.8% during the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 24,054 shares of the medical device company’s stock valued at $2,221,000 after purchasing an additional 193 shares during the period. OMERS ADMINISTRATION Corp increased its position in shares of Cooper Companies by 21.0% during the 4th quarter. OMERS ADMINISTRATION Corp now owns 8,328 shares of the medical device company’s stock valued at $766,000 after purchasing an additional 1,444 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Cooper Companies by 4.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,044 shares of the medical device company’s stock valued at $1,383,000 after purchasing an additional 629 shares during the period. Finally, Lighthouse Investment Partners LLC acquired a new position in shares of Cooper Companies during the 4th quarter valued at $919,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $80.47 on Thursday. The stock has a market cap of $16.09 billion, a PE ratio of 41.27, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08. The business has a fifty day simple moving average of $80.13 and a 200-day simple moving average of $90.52. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12 month low of $69.81 and a 12 month high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analysts Set New Price Targets

COO has been the topic of several research analyst reports. Piper Sandler reiterated an “overweight” rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Citigroup reduced their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Finally, Stifel Nicolaus reduced their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.